Marvel Biosciences Corp. (MRVL.V)

CAD 0.1

(-9.09%)

Revenue Summary of Marvel Biosciences Corp.

Marvel Biosciences Corp.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
Marvel Biosciences Corp.'s latest quarterly revenue in 2024 Q3 was - CAD , down 0.0% from previous quarter.
Marvel Biosciences Corp. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
Marvel Biosciences Corp. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
Marvel Biosciences Corp. reported a quarterly revenue of - CAD for 2024 Q2, down 0.0% from previous quarter.
Marvel Biosciences Corp. reported a quarterly revenue of - CAD for 2024 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Marvel Biosciences Corp. (2023 - 2019)

Historical Annual Revenue of Marvel Biosciences Corp. (2023 - 2019)

Year	Revenue	Revenue Growth
2023	- CAD	0.0%
2022	- CAD	0.0%
2021	- CAD	0.0%
2020	- CAD	0.0%
2019	- CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q3	- CAD	0.0%
2024 Q2	- CAD	0.0%
2024 Q1	- CAD	0.0%
2023 Q2	- CAD	0.0%
2023 FY	- CAD	0.0%
2023 Q3	- CAD	0.0%
2023 Q4	- CAD	0.0%
2023 Q1	- CAD	0.0%
2022 Q1	- CAD	0.0%
2022 FY	- CAD	0.0%
2022 Q4	- CAD	0.0%
2022 Q2	- CAD	0.0%
2022 Q3	- CAD	0.0%
2021 Q2	- CAD	0.0%
2021 Q1	- CAD	0.0%
2021 FY	- CAD	0.0%
2021 Q3	- CAD	0.0%
2021 Q4	- CAD	0.0%
2020 FY	- CAD	0.0%
2019 FY	- CAD	0.0%

Peer Revenue Comparison of Marvel Biosciences Corp.

Name	Revenue	Revenue Difference
Arch Biopartners Inc.	1.98 Million CAD	100.0%
Covalon Technologies Ltd.	26.59 Million CAD	100.0%
Hemostemix Inc.	- CAD	NaN%
Universal Ibogaine Inc.	1.07 Million CAD	100.0%
Kane Biotech Inc.	148.98 Thousand CAD	100.0%
MedMira Inc.	432.52 Thousand CAD	100.0%
NervGen Pharma Corp.	- CAD	NaN%
XORTX Therapeutics Inc.	- CAD	NaN%